Track your comments!
[x]


When you register, comments on your articles and replies to your comments appear here. Register Now!

Sign in to your account
[x]

Not a Scientific Blogging member yet?

Register Now for a Free Scientificblogging.com Account

  • Customize your profile with pictures, banner, a blogroll and more.
  • Leave comments on articles, add other members to your friend lists, chat with people on the site.
  • Write blog posts that can be seen by hundreds of thousands of readers.

It's free and it only takes a minute!

Already a Scientific Blogging member?

Sign In Now

Banner
By News Staff | March 10th 2008 11:00 PM | Print | E-mail | Track Comments
Scientists have discovered epigenetic changes (i.e. chemical changes to a gene that do not alter the DNA sequence) in individuals with schizophrenia and bipolar disorder. This is the first epigenome-wide investigation in psychiatric research, and this groundbreaking data may be a significant step on the journey to fully understanding major psychosis.

Dr. Arturas Petronis, senior scientist in the Krembil Family Epigenetic Laboratory at the Centre for Addiction and Mental Health (CAMH), and his team studied 12,000 locations on the genome using an epigenomic profiling technology developed at CAMH. Approximately one in every two hundred of these genes showed an epigenetic difference in the brains of psychiatric patients.

Significantly, these changes were noted on genes involved in neurotransmission (the exchange of chemical messages within the brain), brain development, and other processes linked to disease origins.

Dr. Petronis explains that these epigenetic changes may be the missing link in understanding what causes an illness. “The DNA sequence of genes for someone with an illness like schizophrenia and a for someone without a mental illness often look the same; there are no visible changes that explain the cause of a disease. But we now have tools that show us changes in the second code, the epigenetic code, which may give us some very important clues for uncovering the mysteries of major psychosis and other complex non-Mendelian illnesses.”

This proof-of-principle study is the first demonstration of what CAMH epigeneticists have hypothesized for the last 10 years.

“Until now, we only had theories that epigenetic changes were important to understanding what causes major psychosis,” explains Dr. Petronis. “Now we have the tools and expertise to support our theories and we can look at conducting larger studies, which will hopefully give us an even better understanding of psychiatric illnesses. And once we understand the primary molecular causes of an illness, we can advance diagnosis and treatment approaches, and possibly even prevent illness.”

Add a comment

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <sup> <sub> <a> <em> <strong> <center> <cite> <code> <TH><ul> <ol> <li> <dl> <dt> <dd> <img> <br> <p> <blockquote> <strike> <object> <param> <embed> <del> <pre> <b> <i> <table> <tbody> <div> <tr> <td> <h1> <h2> <h3> <h4> <h5> <h6> <hr> <iframe>
  • Lines and paragraphs break automatically.
  • Web page addresses and e-mail addresses turn into links automatically.
CAPTCHA
If you register, you will never be bothered to prove you are human again. And you get a real editor toolbar to use instead of this HTML thing that wards off spam bots.